Meeting
2013 Gastrointestinal Cancers Symposium
Oxaliplatin and capecitabine initially concomitant to radiotherapy then administered in the resting period in high-risk locally advanced rectal cancer.
Authors
Pei-Rong Ding
Sun Yat-sen University Cancer Center
Pei-Rong Ding , Yuan-Hong Gao , Xin An , Gong Chen , Feng-Hua Wang , Mu-Yan Cai , Zhi-Fan Zeng , Ling-Heng Kong , Jun-Zhong Lin , Xiaojun Wu , Zhen-Hai Lu , Li-Ren Li , De-Sen Wan , Zhi-Zhong Pan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 31, 2013 (suppl 4; abstr581)
DOI
10.1200/jco.2013.31.4_suppl.581
Abstract #
581
Poster Bd #
E29
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
SONCAR study: A prospective randomized controlled study on optimized neoadjuvant chemotherapy-oxaliplatin plus CRT in patients with locally advanced rectal cancer.
First Author: Rong-Xin Zhang
Poster
2020 ASCO Virtual Scientific Program
Is there a benefit of oxaliplatin in neoadjuvant treatment of locally advanced rectal cancer? An updated meta-analysis.
First Author: Gaetan Des Guetz
Poster
2020 Gastrointestinal Cancers Symposium
The comparison of mFOLFOXIRI with CAOX/SOX as neoadjuvant chemotherapy for locally advanced rectal cancer.
First Author: Tetsuji Terazawa
Poster
2017 ASCO Annual Meeting
A randomized phase II trial of consolidation chemotherapy after preoperative chemoradiation (preop CRT) versus CRT alone for locally advanced rectal cancer (LARC).
First Author: Sun Young Kim